CHARLOTTE, N.C.--(BUSINESS WIRE)--PeraHealth Inc. announced today the availability of its new product, PeraAnalytics. PeraAnalytics examines large volumes of Electronic Health Record (EHR) data to find intervention opportunities that help clinicians avoid preventable harm.
Using the Rothman Index (RI) Score (the Universal Patient Score™), PeraAnalytics associates this calculated patient acuity measure with actual outcomes from patient populations to identify trends for reliable “earlier” warning systems, helping clinicians target interventions to reduce unplanned readmissions, ICU transfers, sepsis and avoidable deaths.
“PeraAnalytics is uncovering intelligence buried in the ‘big data’ of electronic health records,” said Stephanie Alexander, Chief Executive Officer of Charlotte-based PeraHealth Inc. “Real patient outcomes coupled with the associated RI Score allow our customers to identify at-risk patients much earlier and develop proactive intervention protocols that are saving lives, reducing costly readmissions and avoiding Centers for Medicare and Medicaid Services (CMS) penalties.”
Some of the key reports delivered by PeraAnalytics include the “30-day Readmissions Reduction Audit,” the “Roadmap for Avoiding Unplanned Transfers to Critical Care” and “Proactive Sepsis Intervention Targeting.” These reports, tailored from custom analyses that have produced significant results for some of the nation’s top hospitals and healthcare systems, are now available out-of-the-box with PeraAnalytics.
“PeraAnalytics uses state-of-the-art business intelligence techniques to glean life-saving intelligence from untapped EHR data,” said Edward Yurcisin, Chief Technology Officer for PeraHealth. “It is the next step in building our portfolio of products that brings the RI Score into everyday healthcare use.”
For more information about PeraAnalytics, and to see a demonstration of the product, register for the complimentary webinar, January 15, 2014, 1pm ET.
About PeraHealth Inc.
PeraHealth has spent 10 years building and validating the Rothman Index: a completely new model for predicting patient risk and visualizing patient condition across the continuum of care. Serving as the scientific engine of PeraTrend, the Index is protected by five patents and is squarely rooted in clinical and scientific rigor, with 10 peer-reviewed published journal articles validating its core methodology. The firm’s vision: constantly strive to increase patient safety, transform the EHR into a true clinical decision support tool and support the continuum of care in a seamless fashion – all while continuing to expand the firm’s scientific and clinical impact.
For more information, email jfullerton@perahealth.com or visit www.perahealth.com.
